Epstein, Michael S <br/><br/>
Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program.  [electronic resource] 

 -  The American journal of gastroenterology  07 2019 
 - 1017-1019 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1572-0241 
<br/><br/><label>Standard No.: </label>10.14309/ajg.0000000000000215  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Consumer Product Safety<br/>Drug Approval--methods<br/>Drug Labeling<br/>Humans<br/>Program Evaluation<br/>Risk Evaluation and Mitigation--organization & administration<br/>Safety Management<br/>United States<br/>United States Food and Drug Administration--standards